Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-903,840
Closed -$12.1M 83
2016
Q2
$12.1M Sell
903,840
-71,227
-7% -$1.18M 0.83% 35
2016
Q1
$14.9M Hold
975,067
0.91% 32
2015
Q4
$14.5M Hold
975,067
0.81% 34
2015
Q3
$12.9M Buy
975,067
+181,600
+23% +$3.08M 0.44% 41
2015
Q2
$17.7M Sell
793,467
-85,731
-10% -$2.15M 0.27% 40
2015
Q1
$17.8M Buy
879,198
+21,937
+3% +$408K 0.99% 24
2014
Q4
$14.1M Buy
857,261
+118,694
+16% +$1.85M 0.7% 40
2014
Q3
$11.3M Sell
738,567
-31,416
-4% -$621K 0.58% 46
2014
Q2
$19.3M Sell
769,983
-90,784
-11% -$2.07M 1.04% 35
2014
Q1
$18M Buy
860,767
+514,850
+149% +$18.3M 1.03% 36
2013
Q4
$13M Buy
+345,917
New +$6.3M 0.76% 45

Other funds holding CYTR

QVT Financial's CYTR Position: Q3 2016 in Review

QVT Financial sold out of CytRx Corp (CYTR) in Q3 2016, closing a stake of 903,840 shares — an estimated $12.1M sold.

QVT Financial first reported a position in CYTR in Q4 2013 and held it in 11 quarters. The position peaked at $19.3M in Q2 2014. 72 funds tracked by Wall St. Rank hold CYTR as of Q3 2016.

  • QVT Financial reported no remaining CytRx Corp position as of Q3 2016 after selling out during the quarter.
  • QVT Financial sold 903,840 CytRx Corp shares in Q3 2016, an estimated $12.1M.
  • QVT Financial first reported a position in CytRx Corp in Q4 2013 and held it in 11 quarters.
  • QVT Financial's CytRx Corp position peaked at $19.3M in Q2 2014.
  • 72 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2016.

Based on QVT Financial's 13F filing for Q3 2016, filed 14 Nov 2016.